Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Jade Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.

Get JBIO alerts

About Allison Dorval

Allison Dorval is recorded as Board Member at Jade Biosciences, Inc. (JBIO) since July 15, 2021. Jade Biosciences, Inc. reported in an 8-K filed May 1, 2025 that Allison Dorval resigned as Aerovate's board of directors, effective April 28, 2025. The same filing states: “On April 28, 2025, Timothy Noyes, Habib Dable, Allison Dorval, David Grayzel, M.D., Mark Iwicki, Joshua Resnick, M.D. and Donald Santel resigned from Aerovate’s board of directors and its committees on which they respectively served, which resignations were not the result of any disagreements with the Company relating to the Company’s operations, policies or practices.” Jade Biosciences, Inc. reported in an 8-K filed July 19, 2021 that Allison Dorval was appointed member of the Board, effective July 15, 2021. Jade Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Jade Biosciences, Inc. includes Tom Frohlich (CEO and Board Member), Eric Dobmeier (Chairman and Board Member), Bradford Dahms (CFO) and 7 others.

“On April 28, 2025, Timothy Noyes, Habib Dable, Allison Dorval, David Grayzel, M.D., Mark Iwicki, Joshua Resnick, M.D. and Donald Santel resigned from Aerovate's board of directors and its committees on which they respectively served, which resignations were not the result of any disagreements with the Company relating to the Company's operations, policies or practices.”
“On April 28, 2025, Timothy Noyes, Habib Dable, Allison Dorval, David Grayzel, M.D., Mark Iwicki, Joshua Resnick, M.D. and Donald Santel resigned from Aerovate’s board of directors and its committees on which they respectively served, which resignations were not the result of any disagreements with the Company relating to the Company’s operations, policies or practices.”
Jade Biosciences, Inc. Form 8-K, filed May 1, 2025 · Read the filing
“the Board appointed Allison Dorval as a member of the Board, effective as of July 15, 2021 (the “Effective Date”).”
Jade Biosciences, Inc. Form 8-K, filed July 19, 2021 · Read the filing

Affiliation history

Company network

Leadership on record at Jade Biosciences, Inc.

Recent activity